Title Category Credit Event date Cost
Autism Spectrum Disorder Part II: Medical Home Care for Children with ASD and Other Developmental Disabilities
  • Pediatrics
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • APA
  • Attendance
  • CCMC - General
$0.00 Individuals with ASD have a wide range of strengths and weaknesses. ASD is a complex neurobehavioral disorder characterized by impaired social interactions, difficulty with verbal and nonverbal communication, rigid routines and repetitive behaviors, and limited activities and interests.
Management of Comorbid Behavioral and Physical Illness Near the End of Life
  • Behavioral health
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • APA
  • Attendance
  • CCMC - General
$0.00 Comorbid mental and physical diseases constitute a major challenge for HCPs and the health care system, particularly when caring for individuals near the end of life. Understanding the causes may aid in the prevention and management of comorbid behavioral and physical illness near the end of life.
Autism Spectrum Disorder Part I: Overview, Screening, Diagnosis and Treatment Planning
  • Pediatrics
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • APA
  • Attendance
  • CCMC - General
$0.00 Individuals with ASD have a wide range of strengths and weaknesses. ASD is a complex neurobehavioral disorder characterized by impaired social interactions, difficulty with verbal and nonverbal communication, rigid routines and repetitive behaviors, and limited activities and interests.
The Relationship Between Physical and Behavioral Health
  • Behavioral health
  • AMA
  • ANCC
  • APA
  • Attendance
$0.00 Medical science increasingly recognizes the vital link between physical and behavioral health. Physical illnesses like diabetes, cardiovascular disease and musculoskeletal pain are associated with behavioral illnesses. Likewise, individuals with behavioral illnesses such as depression or anxiety disorder are also more likely to experience poor physical health. These findings indicate that primary HCPs would benefit from additional support in investigating and diagnosing behavioral illnesses in individuals with chronic physical conditions.
Health Care Ethics and Safety: A Quality Case for Consumer Engagement*
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • APA
  • CCMC - Ethics
  • CDR
$0.00 Building a culture of health and well-being for those we care for means promoting compassionate, high-quality, efficient and person-centered care. When individuals and their families believe that we place their well-being at the center of what we do, there is a greater likelihood that outcomes will improve. In acute care settings, this might mean greater treatment adherence, shorter lengths of stay and fewer medication errors. However, HCPs often experience significant compassion fatigue and may dismiss compassion as less important than other aspects of care.
Pharmacy Benefit Management Technician Certification Program: Module 1
  • Pharmacy benefit management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • Attendance
$25.00 The purpose of this three-part series is to promote learning about PBM. This series was designed for those interested in learning more about managed care pharmacy and PBM. Module 1 introduces PBM and general pharmacy knowledge; module 2 covers the Health Insurance Portability and Accountability Act (HIPAA), formularies, plan types and claim adjudication; and module 3 discusses prior authorizations, drug utilization reviews and various service levels.Learning objectivesAt the end of this educational activity, participants should be able to:
Pharmacy Benefit Management Technician Certification Program: Module 2
  • Pharmacy benefit management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • Attendance
$25.00 The purpose of this three-part series is to promote learning about PBM. This series was designed for those interested in learning more about managed care pharmacy and PBM. Module 1 introduces PBM and general pharmacy knowledge; module 2 covers the Health Insurance Portability and Accountability Act (HIPAA), formularies, plan types and claim adjudication; and module 3 discusses prior authorizations, drug utilization reviews and various service levels.Learning objectivesAt the end of this educational activity, participants should be able to:
Pharmacy Benefit Management Technician Certification Program: Module 3
  • Pharmacy benefit management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • Attendance
$25.00 The purpose of this three-part series is to promote learning about PBM. This series was designed for those interested in learning more about managed care pharmacy and PBM. Module 1 introduces PBM and general pharmacy knowledge; module 2 covers the Health Insurance Portability and Accountability Act (HIPAA), formularies, plan types and claim adjudication; and module 3 discusses prior authorizations, drug utilization reviews and various service levels.Learning objectivesAt the end of this educational activity, participants should be able to:
Preventive Cardiovascular Care: What is New
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Accumulating evidence has revealed that intestinal microbiota play an important role in human health and disease, including cardiovascular diseases. This activity will discuss the roles of gut microbiota and focus on gut microbes as a factor and therapeutic target in cardiovascular disease. In addition, the latest guidelines for prevention and treatment of co-morbid conditions associated with cardiovascular disease will be reviewed.Learning ObjectivesAt the end of this educational activity, participants should be able to:
Current and Future Applications of Gene Therapy for Various Disease States
  • Disease Management
  • ACPE - Pharmacist
  • ACPE - Pharmacy Technician
  • AMA
  • ANCC
  • Attendance
  • CCMC - General
$0.00 Gene therapy has been investigated as a potential intervention in a number of diseases and/or disorders, including chronic neuropathic pain, melanoma, cardiovascular disease and cancer. This activity will review the latest evidence-based practice guidelines surrounding gene therapies, as well as available safety and efficacy data surrounding its use in a variety of disease states.Learning ObjectivesAt the end of this educational activity, participants should be able to:

Pages